Skip to main content

Peer Review reports

From: An open-label phase 2 trial to assess the efficacy, safety and pharmacokinetics of lanthanum carbonate in hyperphosphatemic children and adolescents with chronic kidney disease undergoing dialysis

Original Submission
27 Jan 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
26 Mar 2021 Reviewed Reviewer Report
19 Apr 2021 Reviewed Reviewer Report
23 Apr 2021 Reviewed Reviewer Report
20 Oct 2021 Author responded Author comments - Anna Wasilewska
Resubmission - Version 5
20 Oct 2021 Submitted Manuscript version 5
22 Oct 2021 Author responded Author comments - Anna Wasilewska
Resubmission - Version 6
22 Oct 2021 Submitted Manuscript version 6
1 Nov 2021 Author responded Author comments - Anna Wasilewska
Resubmission - Version 7
1 Nov 2021 Submitted Manuscript version 7
8 Nov 2021 Reviewed Reviewer Report
9 Nov 2021 Reviewed Reviewer Report
13 Dec 2021 Author responded Author comments - Anna Wasilewska
Resubmission - Version 8
13 Dec 2021 Submitted Manuscript version 8
Publishing
24 Jan 2022 Editorially accepted
2 Mar 2022 Article published 10.1186/s12882-022-02688-9

You can find further information about peer review here.

Back to article page